Clinical Trials Logo

Clinical Trial Summary

This research study is studying racial and genetic biomarkers of response in tissue samples from patients with endometrial cancer. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. DNA analysis of tumor tissue may also help doctors predict how well patients will respond to treatment.


Clinical Trial Description

PRIMARY OBJECTIVES:

I. To identify racial categorization as the proportion of genetic background of African-American or European-American women with endometrioid endometrial cancer (EEC).

II. To evaluate the association of racial genetic admixture with clinicopathologic variables and outcomes.

SECONDARY OBJECTIVES:

I. To compare the concordance between racial genetic admixture and self-designated race categorization.

OUTLINE: This is a multicenter study. Patients are stratified by race (African-American vs European-American) and disease stage (I vs II vs III vs IV).

DNA from archived frozen normal tissue samples is genotyped for the ancestry informative markers. Clinicopathological and demographic characteristics associated with each sample are also collected. ;


Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01198171
Study type Observational
Source Gynecologic Oncology Group
Contact
Status Not yet recruiting
Phase N/A
Start date January 2100

See also
  Status Clinical Trial Phase
Completed NCT01208467 - Prognostic Biomarkers in Patients With Endometrial Cancer N/A
Completed NCT02575872 - Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors N/A
Completed NCT01522820 - Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors Phase 1
Active, not recruiting NCT00956670 - Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer N/A
Completed NCT00897442 - Collecting Tumor Samples From Patients With Gynecological Tumors N/A
Completed NCT01098630 - Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Recruiting NCT03422198 - Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer Phase 3
Not yet recruiting NCT01344837 - Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer N/A
Not yet recruiting NCT01199250 - Biomarkers in Samples From Patients With Endometrial Cancer N/A
Terminated NCT01041027 - Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer Phase 2
Terminated NCT00577317 - Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer Phase 3
Completed NCT02342730 - Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia N/A
Completed NCT03198286 - Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors N/A
Completed NCT00002706 - Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus Phase 3